New to the Huntington's Disease Lighthouse?
 Welcome to the HDlighthouse!
 Getting started.
 
Home \ Research \ The Brain \ Updates
Error Processing in HD

Background

Huntington's disease (HD) is a genetic disorder expressed by a degeneration of the basal ganglia inter alia accompanied with dopaminergic alterations. These dopaminergic alterations are related to genetic factors i.e., CAG-repeat expansion. The error (related) negativity (Ne/ERN), a cognitive event-related potential related to performance monitoring, is generated in the anterior cingulate cortex (ACC) and supposed to depend on the dopaminergic system. The Ne is reduced in Parkinson's Disease (PD). Due to a dopaminergic deficit in HD, a reduction of the Ne is also likely. Furthermore it is assumed that movement dysfunction emerges as a consequence of dysfunctional error-feedback processing. Since dopaminergic alterations are related to the CAG-repeat, a Ne reduction may furthermore also be related to the genetic disease load.

Methodology/Principle Findings

We assessed the error negativity (Ne) in a speeded reaction task under consideration of the underlying genetic abnormalities. HD patients showed a specific reduction in the Ne, which suggests impaired error processing in these patients. Furthermore, the Ne was closely related to CAG-repeat expansion.

Conclusions/Significance

The reduction of the Ne is likely to be an effect of the dopaminergic pathology. The result resembles findings in Parkinson's Disease. As such the Ne might be a measure for the integrity of striatal dopaminergic output function. The relation to the CAG-repeat expansion indicates that the Ne could serve as a gene-associated “cognitive” biomarker in HD.

# # #
print this
printer friendly
version

 

Read the HDLighthouse Forum. Post your comments
   
Related Topics
Research focusing on the formation of aggregates caused by HD
 
Research related to the role Brain Derived Neurotrophic Factor has on the pathology of HD in the brain
 
Learn more about the clinical trial process, trials that have been conducted and those that are underway.
 
Research related to drugs and supplements that may delay onset and slow progression of Huntington's Disease.
 
Research focusing on gene therapy.
 
Research focusing on gene transcription.
 
General research related to HD
 
Research studying the genetics of Huntington's Disease
 
Research studying the Immune System and it's effect on the progression of HD
 
Research studying the brain tissue and research related to stem cells
 

Recent Updates
26 Sep 2007
Press release for the BDNF neurogenesis study.
 
25 Aug 2007
Gene Expression Analysis and Extra-Mitochondrial Energy Metabolism
The HD protein causes a depletion in cellular energy but not through direct effects on the mitochondria, the cell's energy factory.
 
24 Aug 2007
RE1/NRSE Mediated Gene Transcription
Exciting research suggests that restoring the expression of the genes that the HD protein suppresses could be a major treatment.
 
20 Aug 2007
The Molecular Zip Code Research Yields a Drug Target
The molecular zip code research suggests that a kinase inhibitor could be a major treatment for Huntington
 
19 May 2007
D1 receptors and HD
Researchers generated a mouse which progressively lost Dopamine 1 receptor cells and got Huntington's Disease like symptoms.
 
1 Apr 2007
Copper in the HD brain
Researchers have discovered that excess copper plays a role in Huntington's Disease pathology.
 
13 Feb 2007
Molecular Zipcodes Provide Address for HD Protein
New findings based on new technology show that the HD protein is being misdirected within the cell. Small molecules are being developed which might place a 'molecular zip code' on the problem.
 
6 Feb 2007
NCAMs in the HD mice
Problems with NCAMs may explain cognitive and olfactory dysfunction in HD.
 
19 Dec 2006
Stem Cells and The Aging Brain
Stem cells are still present in the middle aged brain; they just aren't dividing.
 
8 Dec 2006
ReNeuron Files Application with FDA to Begin Phase I Study of Stem Cell Treatment for Stroke Patients.
A company currently doing stem cell research in animal models of HD, has filed an application with the FDA for permission to begin clinical trials of stem cell treatments for stroke victims.
 

All Updates for The Brain
Disclaimer & Privacy Policy | Welcome | Site Feedback Marsha@HDLighthouse.org